News
Compounded weight loss drugs have been mostly off the market for about a month, but the weight loss drug industry remains as ...
GLP-1 drugs like Ozempic and Zepbound are great at promoting weight loss, but they also cause folks to lose muscle along with ...
Novo Nordisk had been providing Hims & Hers with the FDA-approved Wegovy, an injectable semaglutide used for weight loss ...
Danish drugmaker Novo Nordisk on Tuesday launched its blockbuster weight-loss drug Wegovy in India, three months after Eli ...
Novo Nordisk A/S is hunting for more early-stage deals to pad its pipeline of next-generation obesity drugs, as the drugmaker ...
Amycretin helped patients lose over 24% of their weight, compared with an average of about 17% for Wegovy.
Amgen's long-acting experimental obesity drug MariTide needs to be given at a low starting dose to limit side effects like ...
Amycretin, a new weight-loss treatment from Novo Nordisk, combines two hunger hormones, helping participants lose nearly ...
A new weight loss pill currently undergoing clinical trials could help burn fat and lower blood sugar levels like Ozempic and ...
Patients who took an experimental drug from Eli Lilly & Co. together with Novo Nordisk A/S’s Wegovy maintained muscle while ...
A monthly weight loss drug from Amgen helped people lose about 20% of their body weight, according to the results of a phase ...
Some new medications in development are also trying to solve for a persistent side effect of existing drugs: Patients who ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results